Pravachol Rx Interaction Profile Is Viewed Favorably In Statins OTC Review
Executive Summary
The drug interaction profile of Bristol-Myers Squibb's Pravachol may make the cholesterol-lowering agent a more attractive OTC switch candidate than Merck's Mevacor, members of the statin OTC switch advisory committee suggested.